Publications 2024

Havnes IA, Henriksen HCB, Johansen PW, Bjørnebekk A, Neupane SP, Hisdal J, Seljeflot I, Wisløff C, Jørstad ML, McVeigh J, Jørgensen AP (2024)
Off-label use of clomiphene citrate to treat anabolic androgenic steroid induced hypogonadism upon cessation among men (CloTASH) - A pilot study protocol
MethodsX, 13, 102810
DOI 10.1016/j.mex.2024.102810, PubMed 39022178

Henriksen HCB, Havnes IA, Jørstad ML, Abdullah R, Thorsby PM, Hauger LE, Edvardsen T, Haugaa KH, Almaas VM, Bjørnebekk A (2024)
Treatment-seeking behavior and cardiovascular morbidity among men with anabolic-androgenic steroid use: A cross-sectional study
Scand J Med Sci Sports, 34 (1), e14554
DOI 10.1111/sms.14554, PubMed 38268076

Publications 2023

Henriksen HCB, Havnes IA, Jørstad ML, Bjørnebekk A (2023)
Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study
Subst Abuse Treat Prev Policy, 18 (1), 19
DOI 10.1186/s13011-023-00528-z, PubMed 37013635

Jørstad ML, Scarth M, Torgersen S, Pope HG, Bjørnebekk A (2023)
Clustering psychopathology in male anabolic-androgenic steroid users and nonusing weightlifters
Brain Behav, 13 (7), e3040
DOI 10.1002/brb3.3040, PubMed 37150843

Publications 2022

Scarth M, Havnes IA, Jørstad ML, McVeigh J, Van Hout MC, Westlye LT, Torgersen S, Bjørnebekk A (2022)
Severity of anabolic steroid dependence, executive function, and personality traits in substance use disorder patients in Norway
Drug Alcohol Depend, 231, 109275
DOI 10.1016/j.drugalcdep.2022.109275, PubMed 35030506

Scarth M, Jørstad ML, Reierstad A, Klonteig S, Torgersen S, Hullstein IR, Bjørnebekk A (2022)
Psychopathology among anabolic-androgenic steroid using and non-using female athletes in Norway
J Psychiatr Res, 155, 295-301
DOI 10.1016/j.jpsychires.2022.09.023, PubMed 36170757

Publications 2021

Hauger LE, Havnes IA, Jørstad ML, Bjørnebekk A (2021)
Anabolic androgenic steroids, antisocial personality traits, aggression and violence
Drug Alcohol Depend, 221, 108604
DOI 10.1016/j.drugalcdep.2021.108604, PubMed 33621808

Publications 2020

Havnes IA, Jørstad ML, Innerdal I, Bjørnebekk A (2020)
Anabolic-androgenic steroid use among women - A qualitative study on experiences of masculinizing, gonadal and sexual effects
Int J Drug Policy, 95, 102876
DOI 10.1016/j.drugpo.2020.102876, PubMed 32736958

Havnes IA, Jørstad ML, McVeigh J, Van Hout MC, Bjørnebekk A (2020)
The Anabolic Androgenic Steroid Treatment Gap: A National Study of Substance Use Disorder Treatment
Subst Abuse, 14, 1178221820904150
DOI 10.1177/1178221820904150, PubMed 32127749

Publications 2019

Bjørnebekk A, Westlye LT, Walhovd KB, Jørstad ML, Sundseth ØØ, Fjell AM (2019)
Cognitive performance and structural brain correlates in long-term anabolic-androgenic steroid exposed and nonexposed weightlifters
Neuropsychology, 33 (4), 547-559
DOI 10.1037/neu0000537, PubMed 31033318

Hauger LE, Sagoe D, Vaskinn A, Arnevik EA, Leknes S, Jørstad ML, Bjørnebekk A (2019)
Anabolic androgenic steroid dependence is associated with impaired emotion recognition
Psychopharmacology (Berl), 236 (9), 2667-2676
DOI 10.1007/s00213-019-05239-7, PubMed 30941469

Havnes IA, Jørstad ML, Wisløff C (2019)
Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires
Subst Abuse Treat Prev Policy, 14 (1), 20
DOI 10.1186/s13011-019-0206-5, PubMed 31096999

Publications 2018

Jørstad ML, Skogheim TS, Bergsund HB (2018)
[Not Available]
Nordisk Alkohol Nark, 35 (1), 69-76
DOI 10.1177/1455072517748871, PubMed 32934514

Publications 2016

Bjørnebekk A, Walhovd KB, Jørstad ML, Due-Tønnessen P, Hullstein IR, Fjell AM (2016)
Structural Brain Imaging of Long-Term Anabolic-Androgenic Steroid Users and Nonusing Weightlifters
Biol Psychiatry, 82 (4), 294-302
DOI 10.1016/j.biopsych.2016.06.017, PubMed 27616036